English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Involvement of Bile Acid Metabolism and Gut Microbiota in the Amelioration of Experimental Metabolism-Associated Fatty Liver Disease by Nobiletin Journal article
Xu, Hongling, Yuan, Mingming, Niu, Kailin, Yang, Wei, Jiang, Maoyuan, Zhang, Lei, Zhou, Jing. Involvement of Bile Acid Metabolism and Gut Microbiota in the Amelioration of Experimental Metabolism-Associated Fatty Liver Disease by Nobiletin[J]. Molecules, 2024, 29(5), 976.
Authors:  Xu, Hongling;  Yuan, Mingming;  Niu, Kailin;  Yang, Wei;  Jiang, Maoyuan; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:4.2/4.6 | Submit date：2024/04/02
Bile Acid  Farnesoid x Receptor  Gut Microbiota  Metabolism-associated Fatty Liver Disease  Nobiletin  
Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism Journal article
Wang, Songsong, Sheng, Feiya, Zou, Liang, Xiao, Jianbo, Li, Peng. Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism[J]. Journal of Advanced Research, 2021, 34, 109-122.
Authors:  Wang, Songsong;  Sheng, Feiya;  Zou, Liang;  Xiao, Jianbo;  Li, Peng
Favorite | TC[WOS]:68 TC[Scopus]:70  IF:11.4/11.0 | Submit date：2022/01/14
Bile Acid Metabolism  Cholesterol Metabolism  Hyperoside  Label-free Proteomics  Nafld  Targeted Metabolomics